OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Vaccination for SARS-CoV-2 in Hematological Patients
Niccolò Riccardi, Marco Falcone, Dafna Yahav
Acta Haematologica (2022) Vol. 145, Iss. 3, pp. 257-266
Open Access | Times Cited: 14

Showing 14 citing articles:

Vaccination of Adults With Cancer: ASCO Guideline
Mini Kamboj, Kari Bohlke, Deana M. Baptiste, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 14, pp. 1699-1721
Closed Access | Times Cited: 17

The unique presentation of SARS-CoV-2 Infection in patients with B-cell depletion: definition of ‘persistent inflammatory sero-negative COVID’
Ana Belkin, Avshalom Leibowitz, Liat Shargian, et al.
Clinical Microbiology and Infection (2022) Vol. 29, Iss. 1, pp. 1-3
Open Access | Times Cited: 27

Efficacy of COVID-19 Booster Vaccines in Patients with Hematologic Malignancies: Experiences in a Real-World Scenario
Carolin Krekeler, Lea Reitnauer, Ulrike Bacher, et al.
Cancers (2022) Vol. 14, Iss. 22, pp. 5512-5512
Open Access | Times Cited: 18

Cancer immunotherapy of Wilms tumor: a narrative review
Yu Lin He, Jin Yan Liu, Rahma Taher Almgrami, et al.
Future Oncology (2024), pp. 1-10
Closed Access | Times Cited: 1

Covid-19 in patients with haematological malignancies
Hubert Warda, Katarzyna Skórka, Krzysztof Giannopoulos
Acta Haematologica Polonica (2024) Vol. 55, Iss. 2, pp. 73-89
Open Access | Times Cited: 1

Serological and cellular response to mRNA-SARS-CoV2 vaccine in patients with hematological lymphoid malignancies: Results of the study “Cervax”
Sara Mohamed, Elisa Lucchini, Francesca Sirianni, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 2

Real-world clinical effectiveness of Tixagevimab/Cilgavimab and Regdanvimab monoclonal antibodies for COVID-19 treatment in Omicron variant-dominant period
Daria Fomina, Marina S. Lebedkina, Anna A. Iliukhina, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 2

Vaccines and Other Preventative Strategies for Immunocompromised Pneumonia
Thomas M. File
Clinics in Chest Medicine (2024) Vol. 46, Iss. 1, pp. 21-35
Closed Access

Predictors of survival in elderly patients with coronavirus disease 2019 admitted to the hospital: derivation and validation of the FLAMINCOV score
Giusy Tiseo, Ili Margalit, Marco Ripa, et al.
Clinical Microbiology and Infection (2022) Vol. 29, Iss. 3, pp. 379-385
Open Access | Times Cited: 3

A Prospective Study Regarding the Efficacy and Safety of the BNT162b2 Vaccine in Patients With Solid Malignancies Undergoing Systemic Chemotherapy
Eiki Yamasaki, Fukutaro Shimamoto, Hiroki Nishikawa, et al.
In Vivo (2022) Vol. 36, Iss. 6, pp. 2780-2789
Open Access | Times Cited: 2

SARS-CoV-2 Vaccination IgG Antibody Responses in Patients with Hematologic Malignancies in a Myeloid Enriched Cohort: A Single Center Observation
Fieke W. Hoff, Suleyman Yasin Goksu, Naveen Premnath, et al.
Acta Medica Academica (2023) Vol. 52, Iss. 1, pp. 30-36
Open Access

Respuesta inmunológica a la vacunación y riesgo de COVID-19 en adultos con neoplasias hematológicas
Jorge Alberto Cortés, Laura Cristina Nócua-Báez, Cándida Díaz‐Brochero, et al.
Revista chilena de infectología (2023) Vol. 40, Iss. 3, pp. 228-235
Open Access

Clinical Course and Prophylaxis of COVID-19 in Patients with Myeloproliferative Diseases
В.М. Мицура, Д.К. Новик, Д.В. Кравченко, et al.
Гематология Трансфузиология Восточная Европа (2022), Iss. 2, pp. 103-109
Open Access

Page 1

Scroll to top